Similar articles for PMID: 28668855

Year	Number of Results
1953	1
1981	1
1996	1
1997	2
2002	2
2003	1
2004	2
2005	4
2006	3
2007	5
2008	3
2009	2
2011	1
2012	3
2013	1
2014	4
2015	2
2016	3
2017	2
2018	1
2019	1
2020	1
2021	1
2022	1

1

Slow-release L-Cysteine (Acetium®) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention.

Syrjänen K, Eronen K, Hendolin P, Paloheimo L, Eklund C, Bäckström A, Suovaniemi O. Syrjänen K, et al. Anticancer Res. 2017 Jul;37(7):3639-3648. doi: 10.21873/anticanres.11734. Anticancer Res. 2017. PMID: 28668855 Clinical Trial.

2

Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention.

Syrjänen K, Salminen J, Aresvuo U, Hendolin P, Paloheimo L, Eklund C, Salaspuro M, Suovaniemi O. Syrjänen K, et al. Anticancer Res. 2016 May;36(5):2297-306. Anticancer Res. 2016. PMID: 27127136 Clinical Trial.

3

Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.

Shiffman S. Shiffman S. Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019. Clin Ther. 2008. PMID: 18803988 Clinical Trial.

4

A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.

Xiao D, Kotler M, Kang J, Wang C. Xiao D, et al. J Addict Med. 2020 Jan/Feb;14(1):69-77. doi: 10.1097/ADM.0000000000000547. J Addict Med. 2020. PMID: 31658113 Free PMC article. Clinical Trial.

5

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.

Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR. Moolchan ET, et al. Pediatrics. 2005 Apr;115(4):e407-14. doi: 10.1542/peds.2004-1894. Pediatrics. 2005. PMID: 15805342 Clinical Trial.

6

Efficacy of a nicotine lozenge for smoking cessation.

Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR. Shiffman S, et al. Arch Intern Med. 2002 Jun 10;162(11):1267-76. doi: 10.1001/archinte.162.11.1267. Arch Intern Med. 2002. PMID: 12038945 Clinical Trial.

7

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G. Aubin HJ, et al. Addiction. 2004 Sep;99(9):1206-18. doi: 10.1111/j.1360-0443.2004.00814.x. Addiction. 2004. PMID: 15317642 Clinical Trial.

8

The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.

Fagerström K, Russ C, Yu CR, Yunis C, Foulds J. Fagerström K, et al. Nicotine Tob Res. 2012 Dec;14(12):1467-73. doi: 10.1093/ntr/nts018. Epub 2012 Mar 30. Nicotine Tob Res. 2012. PMID: 22467778 Clinical Trial.

9

Subjective effects of the nicotine lozenge: assessment of abuse liability.

Houtsmuller EJ, Henningfield JE, Stitzer ML. Houtsmuller EJ, et al. Psychopharmacology (Berl). 2003 Apr;167(1):20-7. doi: 10.1007/s00213-002-1361-2. Epub 2003 Mar 4. Psychopharmacology (Berl). 2003. PMID: 12616334 Clinical Trial.

10

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL. Robles GI, et al. Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed